Inactive Instrument

Sector ratings Plasmatech Biopharmaceuticals Inc Nasdaq

Stocks

End-of-day quote Nasdaq
- ^USD	-

08-14	Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating	MT
08-13	Abeona Therapeutics Shares Fall After Q2 Miss	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility
REGENERON PHARMACEUTICALS, INC.	83.28B		BBB
MODERNA, INC.	57.94B	-	BBB	-	-
CSL LIMITED	57.77B		A
SAMSUNG BIOLOGICS CO.,LTD.	51.75B		BBB
UCB	49.35B		AA
BIOGEN INC.	32.03B		AA
INCYTE CORPORATION	25.91B		AA
INNOVENT BIOLOGICS, INC.	22.74B		AAA
SWEDISH ORPHAN BIOVITRUM AB	16.87B		AA
ALTEOGEN INC.	16.08B		CCC
BRIDGEBIO PHARMA, INC.	15.93B	-	BB	-	-
BIOMARIN PHARMACEUTICAL INC.	12.91B		BBB		-
AXSOME THERAPEUTICS, INC.	10.88B	-	BBB	-	-
KRYSTAL BIOTECH, INC.	10.26B	-	B	-	-
TWIST BIOSCIENCE CORPORATION	9.13B	-	BB	-	-
GRIFOLS, S.A.	6.97B		BB
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	6.35B	-	-	-	-	-
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC	6.17B		B
GAN & LEE PHARMACEUTICALS.	6.06B		-		-
Average	26.23B		A
Weighted average by Cap.			A